Laser technology being developed by Glucosense Diagnostic, Ltd. could end the need for finger sticking… Professor Gin Jose and his team at the University of Leeds have designed a device that measures blood glucose without drawing blood. The device uses nano-engineered silica glass containing ions that fluoresce when a low-powered …

Recent study has shown that inhaled cannabis has a dose-dependent reduction in pain intensity… Almost half of diabetes patients experienced diabetic peripheral neuropathy through their lifetime. Previous animal studies suggest that cannabis may be effective in reducing neuropathic pain, but there were no studies to focus especially on patients with …

More and more Americans on-the-go are skipping the “most important meal of the day,” not eating until lunch… This tendency to miss breakfast has already been linked to the growing epidemic of obesity and cardiovascular problems in the U.S. — and it may put the health of diabetics at risk …

1 in 10 men between the ages of 40 and 59 reporting ED had undiagnosed diabetes in a recent study… Results of a recent study indicate that erectile dysfunction, particularly in middle-aged men, may be a strong indicator of diabetes. The findings highlight the importance for providers to screen any …

Rexlemestrocel-L (mesoblast) can reduce A1c after a single intravenous infusion…

In countries with a high-burden of tuberculosis (TB), it has been well established that there is an increased incidence of TB among patients with diabetes. Diabetes patients face up to a sevenfold increased likelihood of having tuberculosis compared to the general population. However, in countries with a low burden of …

ADA’s one-size-fits-all guidelines might be unrealistic, says the author of a new study in Diabetes Care. Only 35% of more than 5,000 diabetes patients evaluated met targets for A1C and LDL cholesterol levels and blood pressure, with more white than black patients meeting the targets. Researchers found 72% of patients …

The accuracy of blood glucose meters (BGMs) in the low glycemic range is questionable, according to an observation published letter. This prompts concerns regarding safety for measuring blood glucose and when BGMs are used in trials. Noting that the U.S. Food and Drug Administration draft guidance for over-the-counter BGMs requires …

There is an issue with the bolus screen display. The wrong bolus amount may appear on the screen due to an error with the Bolus Wizard. The company is telling patients that blood glucose levels based on a bolus that is more than 12 minutes old should not be used …

Auvi-Q (epinephrine injection, USP) is used to treat life-threatening allergic reactions (anaphylaxis) in people who are at risk for or have a history of these reactions. The first and only compact epinephrine auto‑injector for severe allergic reactions that talks you through the injection process step by step. It comes in …